Subsequently, based on the results of functional experiments and the mouse xenograft model, we verify that LINC00945 promotes proliferation, EMT, migration and invasion of glioma cells, and tumor growth in vivo, suggesting that LINC00945 may serve as a novel underlying therapeutic target for glioma. The gene discussed is LINC00945; the disease is central nervous system cancer.